Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Brett Gardiner
  • September 30, 2020
  • Webinars

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape

Tuesday 27th October 2020 15:00GMT / 16:00 CET / 11:00 EDT

Register now for our next live webinar in which our specialist market access team will share insights from our COVID-19 impact study and advise how biopharmaceutical companies can keep up with pricing and market access activity.

read more »

  • Posted by Harrison Gaiger
  • September 29, 2020
  • Articles

Fake news pandemic: The rise of healthcare misinformation in the age of COVID-19

Fake news pandemic: The rise of healthcare misinformation in the age of COVID-19

Harrison Gaiger explores the Coronavirus myths and mistruths that have flooded social media and the human cost of healthcare misinformation.

In February of this year, Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) warned of a wave of false information that would impede an effective public health response to COVID-19 and create confusion and distrust among people all over the world. He claimed that we were not just fighting an epidemic but also an ‘infodemic’ – an abundance of information, some accurate some not, that would spread faster and more easily than the virus, making it difficult to identify what is true and what is false. It was just a few weeks later that Dr Adhanom Ghebreyesus announced to the world that the COVID-19 outbreak could be characterised as a global pandemic. With almost no country in the world unaffected, and with fear for the future increasing, the wave of misinformation he warned us about was in danger of becoming a tsunami.

read more »

  • Posted by Pei Li Teh & An-hwa Lee
  • September 8, 2020
  • Webinars

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Our experts consider the impact the pandemic has and will continue to have on marketing in global healthcare and look at the continued shift towards digital communications as a means to engage physicians and patients.  

read more »

  • Posted by Dan Coffin
  • August 21, 2020
  • Articles

Why pharma must trust the science of behaviour

Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin explained why the application of behavioural science will be key to better health far beyond COVID-19.

Last month, as the world began to tiptoe its way out of lockdown, a Sky News anchor declared that COVID-19 had ‘exposed behavioural science’ as ‘a load of nonsense’. The rationale? That behavioural scientists’ influence over the UK government’s COVID response caused a delay in lockdown that cost thousands of lives. The scientists’ logic was that if restrictions were imposed too early, ‘behavioural fatigue’ would soon set in and people might sleepwalk back into dangerous habits before the pandemic had peaked. Increases in road traffic that began three weeks into lockdown suggest the thinking had some merit. But the subsequent death toll – and hindsight – tell a different story. Today, months into a crisis where we’re consistently told to ‘trust the science’, the science of behaviour is under the microscope. However, to debate behavioural theory solely through the lens of the coronavirus – using death as the guiding metric – is to minimise its value. Human behaviour is complex, but understanding what drives it – and designing communications that encourage people to do things differently – is key to facilitating positive change. Dismissing behavioural science as blather – a bitter irony in Sky News’ case, given the broadcaster’s mastery of conscious bias…

read more »

  • Posted by Pei Li Teh & An-hwa Lee
  • August 4, 2020
  • Webinars

Digital #MRX: How to use the latest technology to conduct market research in the age of COVID-19 and beyond

Digital #MRX: How to use the latest technology to conduct market research in the age of COVID-19 and beyond

Our experts explore some of the digital methodologies that can best be used to meet your research objectives throughout the product lifecycle.

Watch this webcast in which digital research experts Pei Li Teh and An-hwa Lee outline some of the digital methodologies that can best be used to meet your research objectives throughout the product lifecycle. From market assessment and understanding through to launching your brand and beyond. In particular, they focus on qualitative digital methods and discuss a range of tools from online communities and bulletin boards, virtual IDIs and groups, backroom brainstorms, WeChat and our proprietary mobile techniques Rx Potential, Rx Rationale and iComply. They also explore digital ethnography methods and platforms that are not only immersive and bring insights to life, but provide an additional depth of understanding.

read more »